KORU MEDICAL SYSTEMS, INC. Revenue
KORU MEDICAL SYSTEMS, INC. (KRMD) reported Revenue of $12.05 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2026-08-05
- KORU MEDICAL SYSTEMS, INC. revenues for the quarter ending 2026-06-30 was $12.05M, a 18.15% increase year-over-year.
- KORU MEDICAL SYSTEMS, INC. revenues for the quarter ending 2026-03-31 was $11.76M, a 22.10% increase year-over-year.
- KORU MEDICAL SYSTEMS, INC. revenues for the quarter ending 2025-12-31 was $10.90M, a 23.27% increase year-over-year.
- KORU MEDICAL SYSTEMS, INC. revenues for the quarter ending 2025-09-30 was $10.40M, a 27.17% increase year-over-year.
- KORU MEDICAL SYSTEMS, INC. revenues for fiscal 2025 was $41.13M, a 22.23% increase from fiscal 2024.
- KORU MEDICAL SYSTEMS, INC. revenues for fiscal 2024 was $33.65M, a 17.98% increase from fiscal 2023.
- KORU MEDICAL SYSTEMS, INC. revenues for fiscal 2023 was $28.52M, a 2.23% increase from fiscal 2022.
- KORU MEDICAL SYSTEMS, INC. revenues for fiscal 2022 was $27.90M, a 18.76% increase from fiscal 2021.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2026-06-30 | $12.05M 10-Q · filed 2026-08-05 | $23.81M 10-Q · filed 2026-08-05 | $34.71M derived: sum of 3 quarters · filed 2026-08-05 | $45.11M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $11.76M 10-Q · filed 2026-05-06 | $22.66M derived: sum of 2 quarters · filed 2026-05-06 | $33.06M derived: sum of 3 quarters · filed 2026-05-06 | $43.26M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $10.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $21.30M derived: sum of 2 quarters · filed 2026-03-12 | $31.49M derived: sum of 3 quarters · filed 2026-08-05 | $41.13M 10-K · filed 2026-03-12 |
| 2025-09-30 | $10.40M 10-Q · filed 2025-11-12 | $20.60M derived: sum of 2 quarters · filed 2026-08-05 | $30.23M 10-Q · filed 2025-11-12 | $39.07M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $10.19M 10-Q · filed 2026-08-05 | $19.83M 10-Q · filed 2026-08-05 | $28.67M derived: sum of 3 quarters · filed 2026-08-05 | $36.85M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $9.64M 10-Q · filed 2026-05-06 | $18.47M derived: sum of 2 quarters · filed 2026-05-06 | $26.65M derived: sum of 3 quarters · filed 2026-05-06 | $35.08M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $8.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $17.02M derived: sum of 2 quarters · filed 2026-03-12 | $25.45M derived: sum of 3 quarters · filed 2026-03-12 | $33.65M 10-K · filed 2026-03-12 |
| 2024-09-30 | $8.18M 10-Q · filed 2025-11-12 | $16.61M derived: sum of 2 quarters · filed 2025-11-12 | $24.81M 10-Q · filed 2025-11-12 | $31.99M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $8.43M 10-Q · filed 2025-08-06 | $16.63M 10-Q · filed 2025-08-06 | $23.81M derived: sum of 3 quarters · filed 2025-08-06 | $30.82M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $8.20M 10-Q · filed 2025-05-07 | $15.38M derived: sum of 2 quarters · filed 2025-05-07 | $22.39M derived: sum of 3 quarters · filed 2025-05-07 | $29.32M derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $7.19M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $14.19M derived: sum of 2 quarters · filed 2025-03-12 | $21.13M derived: sum of 3 quarters · filed 2025-03-12 | $28.52M 10-K · filed 2025-03-12 |
| 2023-09-30 | $7.00M 10-Q · filed 2024-11-13 | $13.94M derived: sum of 2 quarters · filed 2024-11-13 | $21.33M 10-Q · filed 2024-11-13 | $28.68M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $6.94M 10-Q · filed 2024-08-07 | $14.33M 10-Q · filed 2024-08-07 | $21.67M derived: sum of 3 quarters · filed 2024-08-07 | $29.43M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $7.39M 10-Q · filed 2024-05-01 | $14.74M derived: sum of 2 quarters · filed 2024-05-01 | $22.50M derived: sum of 3 quarters · filed 2024-05-01 | $29.04M derived: sum of 4 quarters · filed 2024-05-01 |
| 2022-12-31 | $7.34M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $15.11M derived: sum of 2 quarters · filed 2024-03-13 | $21.65M derived: sum of 3 quarters · filed 2024-03-13 | $27.90M 10-K · filed 2024-03-13 |
| 2022-09-30 | $7.76M 10-Q · filed 2023-11-08 | $14.31M derived: sum of 2 quarters · filed 2023-11-08 | $20.55M 10-Q · filed 2023-11-08 | $27.04M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $6.55M 10-Q · filed 2023-08-09 | $12.79M 10-Q · filed 2023-08-09 | $19.28M derived: sum of 3 quarters · filed 2023-08-09 | $25.32M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $6.24M 10-Q · filed 2023-05-04 | $12.73M derived: sum of 2 quarters · filed 2023-05-04 | $18.78M derived: sum of 3 quarters · filed 2023-05-04 | $24.30M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $6.49M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $12.53M derived: sum of 2 quarters · filed 2023-03-08 | $18.06M derived: sum of 3 quarters · filed 2023-03-08 | $23.49M 10-K · filed 2023-03-08 |
| 2021-09-30 | $6.04M 10-Q · filed 2022-11-09 | $11.57M derived: sum of 2 quarters · filed 2022-11-09 | $17.00M 10-Q · filed 2022-11-09 | $21.06M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $5.53M 10-Q · filed 2022-08-03 | $10.96M 10-Q · filed 2022-08-03 | $15.02M derived: sum of 3 quarters · filed 2022-08-03 | $21.10M derived: sum of 4 quarters · filed 2022-08-03 |
| 2021-03-31 | $5.43M 10-Q · filed 2022-05-04 | $9.49M derived: sum of 2 quarters · filed 2022-05-04 | $15.57M derived: sum of 3 quarters · filed 2022-05-04 | $23.28M derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | $4.06M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-02 | $10.14M derived: sum of 2 quarters · filed 2022-03-02 | $17.85M derived: sum of 3 quarters · filed 2022-03-02 | $24.18M 10-K · filed 2022-03-02 |
| 2020-09-30 | $6.08M 10-Q · filed 2021-11-10 | $13.79M derived: sum of 2 quarters · filed 2021-11-10 | $20.12M 10-Q · filed 2021-11-10 | $26.34M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $7.71M 10-Q · filed 2021-08-11 | $14.04M 10-Q · filed 2021-08-11 | $20.26M derived: sum of 3 quarters · filed 2021-08-11 | $26.88M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $6.33M 10-Q · filed 2021-05-12 | $12.55M derived: sum of 2 quarters · filed 2021-05-12 | $19.17M derived: sum of 3 quarters · filed 2021-05-12 | $24.52M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $6.22M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $12.84M derived: sum of 2 quarters · filed 2021-03-23 | $18.19M derived: sum of 3 quarters · filed 2021-03-23 | $23.16M 10-K · filed 2021-03-23 |
| 2019-09-30 | $6.62M 10-Q · filed 2020-11-12 | $11.97M derived: sum of 2 quarters · filed 2020-11-12 | $16.94M 10-Q · filed 2020-11-12 | $21.21M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $5.35M 10-Q · filed 2020-08-05 | $10.32M 10-Q · filed 2020-08-05 | $14.59M derived: sum of 3 quarters · filed 2020-08-05 | $19.14M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | $4.97M 10-Q · filed 2020-05-06 | $9.25M derived: sum of 2 quarters · filed 2020-05-06 | $13.79M derived: sum of 3 quarters · filed 2020-05-06 | $18.29M derived: sum of 4 quarters · filed 2020-05-06 |
| 2018-12-31 | $4.27M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | $8.82M derived: sum of 2 quarters · filed 2020-03-04 | $13.32M derived: sum of 3 quarters · filed 2020-03-04 | $17.35M 10-K · filed 2020-03-04 |
| 2018-09-30 | $4.55M 10-Q · filed 2019-11-06 | $9.05M derived: sum of 2 quarters · filed 2019-11-06 | $13.08M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $4.50M 10-Q · filed 2019-08-07 | $8.54M 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | $4.03M 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |